Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with 123I-MIBG

Molecular Medicine Reports

Volumn 6, Issue 6, 2012, Pages 1337-1342

  Chiaravalloti, A ^a   Stefani, A ^a,b   Tavolozza, M ^a   Pierantozzi, M ^a,b   Di Biagio, D ^a   Olivola, E ^a,b   Di Pietro, B ^a   Stampanoni, M ^a,b   Danieli, R ^a   Simonetti, G ^a   Stanzione, P ^a,b   Schillaci, Orazio ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

123I MIBG; Akinetic rigid type; Parkinson's disease; Sympathetic system; Tremor type

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENAL SCINTISCANNING; ADRENERGIC SYSTEM; ADULT; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSSOVER PROCEDURE; DENERVATION; DISEASE DURATION; DRUG UPTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR IMAGING; PARKINSON DISEASE; PHENOTYPE; QUANTITATIVE ANALYSIS; SYMPATHETIC DENERVATION; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

3-IODOBENZYLGUANIDINE; AGE FACTORS; AGED; FEMALE; HEART; HUMANS; HYPOKINESIA; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; SYMPATHECTOMY; TREMOR;

EID: 84868592608     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1104     Document Type: Article

References (30)

1. Somsen GA, Verberne HJ, Fleury E and Righetti A: Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 11: 126-133, 2004. (Pubitemid 38949906)
2. Braak H, Ghebremedhin E, Rüb U, Bratzke H and Del Tredici K: Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318: 121-134, 2004. (Pubitemid 39362633)
3. Kline R C, Swanson DP, Wieland DM, et al: Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22: 129-132, 1981. (Pubitemid 11143204)
4. Spiegel J, Möllers MO, Jost WH, et al: FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 20: 552-561, 2005. (Pubitemid 40862252)
5. Ahlskog JE: Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism Relat Disord 7: 63-70, 2000.
6. Quinn N: Parkinsonism-recognition and differential diagnosis. Br Med J 310: 447-452, 1995.
7. Suzuki M, Urashima M, Oka H, Hashimoto M and Taira K: Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. Neuroreport 18: 1867-1870, 2007. (Pubitemid 350303768)
8. Spiegel J, Hellwig D, Farmakis G, et al: Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 22: 1004-1008, 2007. (Pubitemid 46999298)
9. Hughes A, Daniel SE, Kilford L and Lees AJ: Accuracy of clinical diagnosis of idiopatic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992.
10. Fahn S, Elton RL and members of the UPDRS Development Committee: Unified Parkinson's disease rating scale. Macmillan Healthcare Information, Florhan Park HJ, 1987.
11. Spiegel J, Hellwing D, Samnick S, et al: Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm 114: 331-335, 2007. (Pubitemid 46328648)
12. Schillaci O, Chiaravalloti A, Pierantozzi M, et al: Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT. Int J Mol Med 28: 881-886, 2011.
13. Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM and Barker RA: Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76: 343-348, 1995.
14. Kang GA, Bronstein JM, Masterman DL, et al: Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord 20: 1133-1142, 1995.
15. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ and Britton KE: A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 14: 513-521, 1992.
16. Courbon F, Brefel-Courbon C, Thalamas C, et al: Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 18: 890-897, 2003. (Pubitemid 37021163)
17. Hamada K, Hirayama M, Watanabe H, et al: Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry 74: 423-426, 2003. (Pubitemid 36379361)
18. Kashihara K, Ohno M, Kawada S and Okumura Y: Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with lewy bodies. J Nucl Med 47: 1099-1101, 2006. (Pubitemid 47544904)
19. Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T and Udaka F: Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms? Parkinsonism Relat Disord 12: 284-288, 2006. (Pubitemid 43816337)
20. Saiki S, Hirose G, Sakai K, et al: Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220: 105-111, 2004. (Pubitemid 38622107)
21. Hakusui S, Yasuda T, Yanagi T, et al: A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 49: 81-84, 1994. (Pubitemid 24230274)
22. Pace L, Betocchi S, Losi MA, et al: Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function. Q J Nucl Med Mol Imaging 48: 20-25, 2004. (Pubitemid 39069660)
23. Sawada H, Hoeda T, Yamamoto K, et al: Diagnostc accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 16: 174-182, 2009.
24. Blin J, Dubois B, Bonnet AM, Vidailhet M, Brandabur M and Agid Y: Does ageing aggravate parkinsonian disability? J Neurol Neurosurg Psychiatry 54: 780-782, 1991.
25. Merlet P, Benvenuti C, Moyse D, et al: Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40: 917-923, 1999. (Pubitemid 29269210)
26. Morozumi T, Kusuoka H, Fukuchi K, et al: Myocardial iodine- 123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 38: 49-52, 1997. (Pubitemid 27026996)
27. Kobayashi S, Tateno M, Morii H, Utsumi K and Saito T: Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies. Psychiatry Res 174: 76-80, 2009.
28. Yoshita M, Taki J, Yokoyama K, et al: Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 66: 1850-1854, 2006. (Pubitemid 44049815)
29. Carr J: Tremor in Parkinson's disease. Parkinsonism Relat Disord 8: 223-234, 2002.
30. Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A and Bergman H: Basal ganglia oscillations and pathophysiology of movement disorders. Curr Opin Neurobiol 16: 629-637, 2006. (Pubitemid 44810892)